Linden A, Hansson L, Andersson A, Palmqvist M, Arvidsson P, Lofdahl CG, Larsson P, Lotvall J
Since complications of treatment with glucocorticoids are dependent on the size of the dose and the duration of treatment a risk/benefit decision must be made in each individual case as to dose and duration of treatment and as to whether daily or intermittent therapy should be used
Mechanical and physical properties of LiNi 0.33 Mn 0.33 Co 0.33 O 2 (NMC)
If density declines significantly, interventions include calcium and vitamin D optimization, weight-bearing exercise, and sometimes pharmacologic therapy
A pre-specified cardiovascular meta-analysis from SURPASS programme studies showed that there is no excess cardiovascular risk with tirzepatide use [51], however the ongoing SURPASS-CVOT (NCT04255433) will provide evidence on the definitive impact of tirzepatide on cardiovascular disease in people with T2D (Figure 4)